Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step

  1. Alex A Shestov
  2. Xiaojing Liu
  3. Zheng Ser
  4. Ahmad A Cluntun
  5. Yin P Hung
  6. Lei Huang
  7. Dongsung Kim
  8. Anne Le
  9. Gary Yellen
  10. John G Albeck
  11. Jason W Locasale  Is a corresponding author
  1. Cornell University, United States
  2. Harvard Medical School, United States
  3. Johns Hopkins University School of Medicine, United States
  4. University of California, Davis, United States

Abstract

Aerobic glycolysis or the Warburg Effect (WE) is characterized by the increased metabolism of glucose to lactate. It remains unknown what quantitative changes to the activity of metabolism are necessary and sufficient for this phenotype. We developed a computational model of glycolysis and an integrated analysis using metabolic control analysis (MCA), metabolomics data, and statistical simulations. We identified and confirmed a novel mode of regulation specific to aerobic glycolysis where flux through GAPDH, the enzyme separating lower and upper glycolysis, is the rate-limiting step in the pathway and the levels of fructose (1,6) bisphosphate (FBP), are predictive of the rate and control points in glycolysis. Strikingly, negative flux control was found and confirmed for several steps thought to be rate-limiting in glycolysis. Together these findings enumerate the biochemical determinants of the WE, and suggest strategies for identifying the contexts in which agents that target glycolysis might be most effective.

Article and author information

Author details

  1. Alex A Shestov

    Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  2. Xiaojing Liu

    Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  3. Zheng Ser

    Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  4. Ahmad A Cluntun

    Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  5. Yin P Hung

    Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  6. Lei Huang

    Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  7. Dongsung Kim

    Cornell University, Ithaca, United States
    Competing interests
    No competing interests declared.
  8. Anne Le

    Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    No competing interests declared.
  9. Gary Yellen

    Harvard Medical School, Boston, United States
    Competing interests
    No competing interests declared.
  10. John G Albeck

    University of California, Davis, Davis, United States
    Competing interests
    No competing interests declared.
  11. Jason W Locasale

    Cornell University, Ithaca, United States
    For correspondence
    locasale@cornell.edu
    Competing interests
    Jason W Locasale, A patent related to this work has been filed..

Reviewing Editor

  1. David M Sabatini, Whitehead Institute and the Massachusetts Institute of Technology, United States

Version history

  1. Received: May 11, 2014
  2. Accepted: July 8, 2014
  3. Accepted Manuscript published: July 9, 2014 (version 1)
  4. Version of Record published: August 1, 2014 (version 2)

Copyright

© 2014, Shestov et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,675
    views
  • 1,157
    downloads
  • 211
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alex A Shestov
  2. Xiaojing Liu
  3. Zheng Ser
  4. Ahmad A Cluntun
  5. Yin P Hung
  6. Lei Huang
  7. Dongsung Kim
  8. Anne Le
  9. Gary Yellen
  10. John G Albeck
  11. Jason W Locasale
(2014)
Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step
eLife 3:e03342.
https://doi.org/10.7554/eLife.03342

Share this article

https://doi.org/10.7554/eLife.03342

Further reading

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Katarzyna Marta Zoltowska, Utpal Das ... Lucía Chávez-Gutiérrez
    Research Article

    Amyloid β (Aβ) peptides accumulating in the brain are proposed to trigger Alzheimer’s disease (AD). However, molecular cascades underlying their toxicity are poorly defined. Here, we explored a novel hypothesis for Aβ42 toxicity that arises from its proven affinity for γ-secretases. We hypothesized that the reported increases in Aβ42, particularly in the endolysosomal compartment, promote the establishment of a product feedback inhibitory mechanism on γ-secretases, and thereby impair downstream signaling events. We conducted kinetic analyses of γ-secretase activity in cell-free systems in the presence of Aβ, as well as cell-based and ex vivo assays in neuronal cell lines, neurons, and brain synaptosomes to assess the impact of Aβ on γ-secretases. We show that human Aβ42 peptides, but neither murine Aβ42 nor human Aβ17–42 (p3), inhibit γ-secretases and trigger accumulation of unprocessed substrates in neurons, including C-terminal fragments (CTFs) of APP, p75, and pan-cadherin. Moreover, Aβ42 treatment dysregulated cellular homeostasis, as shown by the induction of p75-dependent neuronal death in two distinct cellular systems. Our findings raise the possibility that pathological elevations in Aβ42 contribute to cellular toxicity via the γ-secretase inhibition, and provide a novel conceptual framework to address Aβ toxicity in the context of γ-secretase-dependent homeostatic signaling.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Ya-Juan Wang, Xiao-Jing Di ... Ting-Wei Mu
    Research Article Updated

    Protein homeostasis (proteostasis) deficiency is an important contributing factor to neurological and metabolic diseases. However, how the proteostasis network orchestrates the folding and assembly of multi-subunit membrane proteins is poorly understood. Previous proteomics studies identified Hsp47 (Gene: SERPINH1), a heat shock protein in the endoplasmic reticulum lumen, as the most enriched interacting chaperone for gamma-aminobutyric acid type A (GABAA) receptors. Here, we show that Hsp47 enhances the functional surface expression of GABAA receptors in rat neurons and human HEK293T cells. Furthermore, molecular mechanism study demonstrates that Hsp47 acts after BiP (Gene: HSPA5) and preferentially binds the folded conformation of GABAA receptors without inducing the unfolded protein response in HEK293T cells. Therefore, Hsp47 promotes the subunit-subunit interaction, the receptor assembly process, and the anterograde trafficking of GABAA receptors. Overexpressing Hsp47 is sufficient to correct the surface expression and function of epilepsy-associated GABAA receptor variants in HEK293T cells. Hsp47 also promotes the surface trafficking of other Cys-loop receptors, including nicotinic acetylcholine receptors and serotonin type 3 receptors in HEK293T cells. Therefore, in addition to its known function as a collagen chaperone, this work establishes that Hsp47 plays a critical and general role in the maturation of multi-subunit Cys-loop neuroreceptors.